The medical-device giant is positioning its Hugo RAS system to compete with Intuitive Surgical's da Vinci systems.

Medtronic plc (NYSE:MDT) ranks among the best medical device stocks to invest in. Following a tour of the company’s HUGO soft ...

First-ever investigational device exemption clinical study for robotic-assisted hernia repair in the U.S. presented at the American Hernia Society annual meeting Primary safety and effectiveness ...

With positive trial results in urology and hernia repair already under its belt, the company is getting closer to taking on ...

The study aims to validate an integrated surgical ecosystem that combines robotics, imaging, instrumentation and workflow optimisation ...

Hugo is already on the market in some countries, but made a slow start commercially. Medtronic cut its sales forecast in 2021, slashing the midpoint of its range from $75 million to $30 million. Sales ...

Medtronic (MDT) just announced the launch of a new clinical study in the U.S. that will test its Hugo robotic-assisted ...

Medtronic has doubled the size of its London office space and increased the site’s headcount to more than 200 to accelerate innovation in robotic surgery and AI-based product development. Located in ...

Medtronic PLC (NYSE:MDT) released on Thursday results from the Enable Hernia Repair clinical study evaluating the performance of the Hugo robotic-assisted surgery (RAS) system in inguinal and ventral ...

DUBLIN and CHENNAI, India, Sept. 27, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT) and Apollo Hospitals Group today announced the first clinical procedure in Asia-Pacific with the Hugo™ ...

Medtronic is bringing on a new chief medical officer for its digital and robotics teams, who it described as one of the top five robotic surgeons in the U.S. James Porter serves as medical director of ...